Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review

被引:0
|
作者
Li Gao
Jun Lu
Jie Li
Yixin Hu
Ye Lu
Weiwei Du
Shaoyan Hu
机构
[1] Children’s Hospital of Soochow University,Department of Hematology and Oncology
来源
关键词
Lineage switch; Acute megakaryoblastic leukemia; Relapse; T cell acute lymphoblastic leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
We present a patient with acute megakaryoblastic leukemia (AMKL) harboring KMT2A-MLLT3 that converted to T cell acute lymphoblastic leukemia (T-ALL) at her fourth relapse. A 4-year-old girl developed AMKL with multiple swollen lymph nodes. She exhibited several recurrences in the bone marrow and died of septic shock after her fourth relapse. Bone marrow cells at the initial diagnosis and at all four relapses had the same KMT2A-MLLT3 fusion transcript. She also developed a somatic mutation (c.7177C > T p.Q2393X) of NOTCH1 at the fourth relapse. This sequential phenotypic and cytogenetic study may yield valuable insights into the mechanism of AMKL to T-ALL lineage switch and possible implications for treatment selection.
引用
收藏
页码:781 / 785
页数:4
相关论文
共 50 条
  • [31] Good Survival of CAR-T Cell Therapy Bridging to Allo-HSCT for Relapsed/Refractory Ph-Positive B-Cell Acute Lymphoblastic Leukemia
    Liu, Zhanxiang
    Wu, Tong
    Song, Yanzhi
    Yuan, Erhui
    Qin, Qishu
    Wang, Qi
    BLOOD, 2023, 142
  • [32] Lineage Switch from Early T-Cell Precursor Acute Lymphoblastic Leukemia to Acute Monoblastic Leukemia Following Treatment with Nelarabine and a Cord Blood Stem Cell Transplantation
    Mizuta, S.
    Yamane, N.
    Kobayashi, K.
    Suehiro, M.
    Maihara, T.
    Usami, I.
    Komai, T.
    Heike, T.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S142 - S142
  • [33] Outcomes of Second Anti-CD19 CAR T-Cell Therapy (CART2) in Acute B Lymphoblastic Leukemia and the Impact of Allo-HSCT on Efficacy
    Xu, Qianwen
    Shi, Yi
    Xue, Lei
    An, Furun
    Xu, Hui
    Liu, Xin
    Zhu, Xiaoyu
    Sun, Zimin
    Zhai, Zhimin
    Wang, Xingbing
    CELL TRANSPLANTATION, 2023, 32
  • [34] Patient-based prediction algorithm of relapse after allo-HSCT for acute Leukemia and its usefulness in the decision-making process using a machine learning approach
    Fuse, Kyoko
    Uemura, Shun
    Tamura, Suguru
    Suwabe, Tatsuya
    Katagiri, Takayuki
    Tanaka, Tomoyuki
    Ushiki, Takashi
    Shibasaki, Yasuhiko
    Sato, Naoko
    Yano, Toshio
    Kuroha, Takashi
    Hashimoto, Shigeo
    Furukawa, Tatsuo
    Narita, Miwako
    Sone, Hirohito
    Masuko, Masayoshi
    CANCER MEDICINE, 2019, 8 (11): : 5058 - 5067
  • [35] COMPARATIVE EFFECTIVENESS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS (ALLO-HSCT) FROM DIFFERENT GRAFT SOURCES IN ACUTE MYELOID LEUKEMIA (AML): RESULTS OF A SYSTEMATIC LITERATURE REVIEW
    Tomaras, D.
    Dolph, M.
    Caudrelier, P.
    Dumont-Lagace, M.
    Forsythe, A.
    VALUE IN HEALTH, 2019, 22 : S60 - S61
  • [36] IS MIXED T-CELL CHIMERISM PREDICTIVE OF RELAPSE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION?
    Khan, Saadiya
    Alsaif, Zainab
    Siddiqi, Khawar
    Al-Jefri, Abdullah
    Alahmari, Ali
    Alanazi, Awatif
    Alsaedi, Hawazen
    Ayas, Mouhab
    Ghemlas, Ibrahim
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S207 - S208
  • [37] Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant
    Cao, Xing-yu
    Zhang, Jian-Ping
    Zhao, Yan-Li
    Xiong, Min
    Zhou, Jiarui
    Lu, Yue
    Sun, Ruijuan
    Wei, Zhijie
    Liu, Deyan
    Zhang, Xian
    Yang, Junfang
    Lu, Peihua
    BLOOD, 2022, 140 : 4802 - 4803
  • [38] Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse
    Higuchi, Yusuke
    Tokunaga, Kenji
    Watanabe, Yuko
    Kawakita, Toshiro
    Harada, Naoko
    Yamaguchi, Shunichiro
    Nosaka, Kisato
    Mitsuya, Hiroaki
    Asou, Norio
    CANCER GENETICS, 2016, 209 (06) : 267 - 271
  • [39] Allo-HSCT in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia Treated with Blinatumomab vs Standard-of-Care Chemotherapy From a Randomized Phase 3 Study
    Jabbour, Elias
    Goekbuget, Nicola
    Thomas, Xavier
    Larson, Richard A.
    Yoon, Sung-Soo
    Ghobadi, Armin
    Tuglus, Catherine
    Zimmerman, Zachary
    Forman, Stephen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S90 - S91
  • [40] Rare KMT2A-ELL and Novel ZNF56-KMT2A Fusion Genes in Pediatric T-cell Acute Lymphoblastic Leukemia
    Panagopoulos, Ioannis
    Andersen, Kristin
    Eilert-Olsen, Martine
    Rognlien, Anne Gro
    Munthe-Kaas, Monica Cheng
    Micci, Francesca
    Heim, Sverre
    CANCER GENOMICS & PROTEOMICS, 2021, 18 (02) : 121 - 131